Akoya Biosciences, Inc.

NASDAQ:AKYA

2.49 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 96.63374.85954.91742.44342.236
Cost of Revenue 40.32831.46920.69916.53517.573
Gross Profit 56.30543.3934.21825.90824.663
Gross Profit Ratio 0.5830.580.6230.610.584
Reseach & Development Expenses 21.88923.21115.7019.6038.761
General & Administrative Expenses 000025.451
Selling & Marketing Expenses 00000.9
SG&A 82.38179.65351.01623.98226.351
Other Expenses 9.7036.7344.7263.8153.055
Operating Expenses 104.27109.59871.44337.438.167
Operating Income -57.668-66.208-37.225-11.492-13.504
Operating Income Ratio -0.597-0.884-0.678-0.271-0.32
Total Other Income Expenses Net -5.615-4.412-3.777-4.653-2.254
Income Before Tax -63.283-70.518-43.075-16.664-14.557
Income Before Tax Ratio -0.655-0.942-0.784-0.393-0.345
Income Tax Expense 0.040.123-0.140.0420.194
Net Income -63.323-70.641-42.935-16.706-14.751
Net Income Ratio -0.655-0.944-0.782-0.394-0.349
EPS -1.43-1.87-1.15-0.45-0.4
EPS Diluted -1.43-1.87-1.15-0.45-0.4
EBITDA -45.632-58.815-35.168-10.126-9.621
EBITDA Ratio -0.472-0.793-0.599-0.18-0.256